Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is pancreatoblastoma?
Pancreatoblastoma is the most common pancreatic cancer of childhood, though it is still very rare. It grows from immature, embryonic-type cells of the pancreas — the gland behind the stomach that makes digestive juices and the hormone insulin. Because it usually starts as a single, often large mass, children may come to attention with a belly lump, pain, or weight loss. About 7 in 10 tumors release a protein called alpha-fetoprotein (AFP) into the blood, which doctors use both to help diagnose the disease and to follow how it responds to treatment. Most cases occur in children, but it can rarely appear in adults, where it tends to behave more aggressively. The single most important factor for cure is whether the tumor can be completely removed.
The main types
Doctors group pancreatoblastoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Childhood pancreatoblastoma | The usual form, found in young children (often under age 10). Tends to respond well to chemotherapy and surgery. |
| Adult pancreatoblastoma | Very rare. Occurs in adults and generally behaves more aggressively, with a higher chance of spread. |
| Beckwith-Wiedemann-associated | Some cases occur in children with the Beckwith-Wiedemann overgrowth syndrome or related genetic conditions, which prompts genetic evaluation. |
Staging, in plain terms
Pancreatoblastoma is not staged with a single fixed system. What matters most is whether the tumor can be completely removed by surgery and whether it has spread (most often to the liver or lungs). Doctors map the tumor's size and its relationship to nearby blood vessels — much like the PRETEXT system used for childhood liver tumors — to plan whether surgery comes first or after chemotherapy.
| Resectability + spread (PRETEXT-style assessment) | What it generally means |
|---|---|
| Localized, resectable | The tumor sits in the pancreas and can be removed with surgery. This is the best scenario, with high cure rates. |
| Localized, unresectable at diagnosis | The tumor is too large or too close to major blood vessels to remove safely at first. Chemotherapy is given to shrink it and make surgery possible. |
| Metastatic | Cancer has spread beyond the pancreas, usually to the liver or lungs. Treated with chemotherapy and surgery when feasible. |
The standard of care
Pancreatoblastoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the key to cure)
Completely removing the tumor is the most important step. Depending on its location this may be a Whipple operation (for tumors in the head of the pancreas) or removal of the body and tail, sometimes sparing the spleen.
Chemotherapy
Cisplatin and doxorubicin (a regimen related to that used for liver tumors) is the backbone. It is given before surgery to shrink large tumors and after surgery to treat any hidden disease.
Radiation — controversial, selective
Radiation is not part of routine care. It is considered case by case, mainly when a tumor cannot be fully removed and disease remains after surgery and chemotherapy.
AFP monitoring
Because most tumors make AFP, falling blood levels reassure the team that treatment is working, and a later rise can flag a recurrence early.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they cannot keep dividing. In pancreatoblastoma it plays only a supporting role — surgery and chemotherapy do most of the work — but when tumor remains that cannot be removed, focused radiation can help control it. Because patients are usually young children, any radiation is delivered with the most precise techniques (IMRT or protons) and in small daily doses to protect the surrounding organs that are still developing. It is painless and leaves no radioactivity in the body.
The main ways radiation is delivered for pancreatoblastoma:
Conformal photon radiation (IMRT/IGRT)
When radiation is needed, image-guided, intensity-modulated beams concentrate the dose on residual tumor while sparing the bowel, kidneys, liver, and spine of a growing child.
Proton beam therapy
Protons stop at a set depth, sparing tissue beyond the target. In children this lowers the long-term dose to developing organs near the pancreas.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Pediatric-center treatment series: A single-center retrospective study confirmed that complete surgical removal combined with cisplatin/doxorubicin chemotherapy gives the best long-term survival, and that preoperative chemotherapy can convert unresectable tumors into operable ones.[1]
Pediatric Surgery International (PubMed 31338582)
Clinical management review: A literature review reinforced that absence of metastases and complete resection are the strongest predictors of cure, and that radiation's role remains limited to incompletely resected disease decided in multidisciplinary review.[2]
J. Pediatric Surgery Case Reports (PMC8857517)
European pediatric rare-tumor guidance: The European Cooperative Study Group for Pediatric Rare Tumors frames cisplatin/doxorubicin plus surgery as standard and recommends genetic evaluation given the link to Beckwith-Wiedemann syndrome.[3]
EXPeRT / raretumors-children.eu
Common questions
Is pancreatoblastoma curable? Often yes, especially in children when the tumor has not spread and can be completely removed. Surgery combined with chemotherapy gives many children a long, disease-free life. The outlook is harder when the cancer has already spread or cannot be fully removed.
Why does my child need surgery and chemotherapy both? Surgery removes the visible tumor, which is essential for cure. Chemotherapy shrinks large tumors before surgery and mops up any microscopic cancer cells afterward, lowering the chance the disease comes back.
What does the AFP blood test tell us? Most pancreatoblastomas release AFP into the blood. A falling level usually means treatment is working, and the test is repeated over time so that a rise can signal a recurrence early, often before symptoms appear.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.